Tirzepatide, the active ingredient in many GLP1 medications is used for weight loss and type 2 diabetes in adults and is a gastric inhibitory polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are the two primary incretin hormones secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic β cells.